Depomed Inc (DEPO)

24.53
0.13 0.53
NASDAQ : Health Care
Prev Close 24.40
Open 24.40
Day Low/High 23.95 / 24.64
52 Wk Low/High 12.25 / 33.16
Volume 1.79M
Avg Volume 1.28M
Exchange NASDAQ
Shares Outstanding 61.37M
Market Cap 1.49B
EPS -1.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Starboard Delivers Special Meeting Request To Depomed And Issues Letter To Depomed Shareholders

Starboard Delivers Special Meeting Request To Depomed And Issues Letter To Depomed Shareholders

Sets November 15, 2016 as the Date for the Special Meeting and Believes Depomed Has Notified Broadridge of a September 27, 2016 Record Date

Depomed Receives Request To Call Special Meeting Of Shareholders

Depomed Receives Request To Call Special Meeting Of Shareholders

Depomed Shareholders Not Required to Take Action at This Time

Stocks End Volatile Week With Fed Meeting in Focus

Stocks End Volatile Week With Fed Meeting in Focus

Wall Street closed out a volatile week with slight losses as the Federal Reserve stays in focus.

Stocks Slide as Oil Settles Barely Above $43

Stocks Slide as Oil Settles Barely Above $43

Stocks hold lower on Friday as crude oil selloff pressures the energy sector and nerves over next week's Federal Reserve meeting peak.

Stocks Hold Lower as Fed Meeting Looms, Crude Slides

Stocks Hold Lower as Fed Meeting Looms, Crude Slides

Stocks fall on Friday as Wall Street eagerly awaits next week's meeting of the Federal Reserve.

Depomed (DEPO) Stock Soars Amid Sale Speculation

Depomed (DEPO) Stock Soars Amid Sale Speculation

Depomed (DEPO) stock was spiking on Friday morning as the company is reportedly preparing to explore a sale.

More Rare Disease Dealmaking to Follow Horizon's Raptor Deal

More Rare Disease Dealmaking to Follow Horizon's Raptor Deal

The buyer's CEO said it will look at both large acquisitions and Phase 2 and pre-approved assets in the wake of the $800 million purchase of the maker of Procysbi.

Perrigo Shares Spike After Starboard's Smith Urges Asset Sales

Perrigo Shares Spike After Starboard's Smith Urges Asset Sales

Perrigo is the second drug company that the activist has targeted in recent months after it rejected an unsolicited bid.

Horizon Pharma Swoops In on Raptor With $800 Million Bid

Horizon Pharma Swoops In on Raptor With $800 Million Bid

Horizon says the $800 million offer will bolster its rare disease business and its operations outside the U.S..

4 Breakout Stocks to Watch

4 Breakout Stocks to Watch

These four stocks are looking strong technically, either breaking out or approaching breakout levels.

Short Interest Declines 12.4% For DEPO

Short Interest Declines 12.4% For DEPO

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 1,640,757 share decrease in total short interest for Depomed Inc , to 11,618,047, a decrease of 12.37% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Depomed (DEPO) Is Strong On High Volume Today

Depomed (DEPO) Is Strong On High Volume Today

Trade-Ideas LLC identified Depomed (DEPO) as a strong on high relative volume candidate

Depomed (DEPO) Weak On High Volume

Depomed (DEPO) Weak On High Volume

Trade-Ideas LLC identified Depomed (DEPO) as a weak on high relative volume candidate

Starboard Delivers Letter To Depomed Shareholders

Starboard Delivers Letter To Depomed Shareholders

Appoints Two Exceptionally Qualified Former Pharmaceutical Executives as Advisors - Robert Savage and James Tyree - Who Would Join Starboard's "All-Star" Slate as Directors if Successful at the Special Meeting

Depomed Announces Patent Trial And Appeal Board Denial Of Inter Partes Review Of NUCYNTA Patent

Depomed Announces Patent Trial And Appeal Board Denial Of Inter Partes Review Of NUCYNTA Patent

- ANDA Litigation Decision Related to this Patent Expected by September 30, 2016 -

Depomed (DEPO): Today's Weak On High Volume Stock

Depomed (DEPO): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Depomed (DEPO) as a weak on high relative volume candidate

Depomed Proposes To Call Special Meeting Of Shareholders On October 28, 2016 Following Outcome Of NUCYNTA Patent Litigation

Depomed Proposes To Call Special Meeting Of Shareholders On October 28, 2016 Following Outcome Of NUCYNTA Patent Litigation

Sets Record Date to Determine Shareholders Entitled to Request Special Meeting Called by Starboard

Insider Trading Alert - DEPO, ARIA And ROG Traded By Insiders

Insider Trading Alert - DEPO, ARIA And ROG Traded By Insiders

Stocks with insider trader activity include DEPO, ARIA and ROG

Starboard Delivers Letter To Depomed Shareholders

Starboard Delivers Letter To Depomed Shareholders

Recommences the Process to Call a Special Meeting of Shareholders for Removing and Replacing the Current Depomed Board with a Modified Slate of Six Highly Qualified Nominees

Sohn Picks Revisited: Mixed Results From David Einhorn & Jeffrey Smith

Results on conference picks are split as hedge fund industry contends with criticism.